Peripheral Vascular Devices | Market Insights | Asia Pacific (Supplemental) | 2024
The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, an expanding patient population, and rising adoption of premium-priced drug-eluting products. Rising procedure volumes for iliac and lower limb indications and the increasing adoption of endovascular techniques over surgical intervention will also fuel market growth. However, cost constraints in publicly funded healthcare systems and limited reimbursement in the region continue to hinder adoption of premium-priced devices and limit the pace of revenue expansion.
This Medtech 360 Report provides high-level market metrics for PV devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2032.
